Biohaven Ltd (NYSE: BHVN) started the day on Thursday, with a price decrease of -3.50% at $45.19, before settling in for the price of $46.83 at the close. Taking a more long-term approach, BHVN posted a 52-week range of $26.80-$62.21.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 0.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -54.39%. This publicly-traded company’s shares outstanding now amounts to $100.95 million, simultaneously with a float of $88.45 million. The organization now has a market capitalization sitting at $4.57 billion. At the time of writing, stock’s 50-day Moving Average stood at $48.96, while the 200-day Moving Average is $43.74.
Biohaven Ltd (BHVN) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Biohaven Ltd’s current insider ownership accounts for 12.38%, in contrast to 86.34% institutional ownership. According to the most recent insider trade that took place on Oct 02 ’24, this organization’s Director bought 21,052 shares at the rate of 47.50, making the entire transaction reach 999,970 in total value, affecting insider ownership by 21,052. Preceding that transaction, on Oct 02 ’24, Company’s Chief Executive Officer bought 21,052 for 47.50, making the whole transaction’s value amount to 999,970. This particular insider is now the holder of 861,942 in total.
Biohaven Ltd (BHVN) Earnings and Revenue Records
Biohaven Ltd’s EPS decrease for this current 12-month fiscal period is -54.39% and is forecasted to reach -6.31 in the upcoming year.
Biohaven Ltd (NYSE: BHVN) Trading Performance Indicators
Let’s observe the current performance indicators for Biohaven Ltd (BHVN). It’s Quick Ratio in the last reported quarter now stands at 2.89. The Stock has managed to achieve an average true range (ATR) of 2.59.
In the same vein, BHVN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -9.35, a figure that is expected to reach -1.61 in the next quarter, and analysts are predicting that it will be -6.31 at the market close of one year from today.
Technical Analysis of Biohaven Ltd (BHVN)
If we take a close look at the recent performances of Biohaven Ltd (NYSE: BHVN), its last 5-days Average volume was 0.87 million that shows plunge from its year to date volume of 1.13 million. During the previous 9 days, stock’s Stochastic %D was recorded 25.67% While, its Average True Range was 2.66.
Raw Stochastic average of Biohaven Ltd (BHVN) in the period of the previous 100 days is set at 54.70%, which indicates a major rise in contrast to 17.03% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 52.83% that was lower than 55.10% volatility it exhibited in the past 100-days period.
